India medical device healthcare

11
India Healthcare and Medical Device industry Analysis Divya Kumar, Neel Mehta, Kavita Tangirala, Jared Mckee HSM502 WP Carey MBA –Class of 2014 Tempe Campus

description

Medical Device in India, India Medical Healthcare, 2012

Transcript of India medical device healthcare

Page 1: India medical device healthcare

India Healthcare and Medical Device industry Analysis

Divya Kumar, Neel Mehta, Kavita Tangirala, Jared MckeeHSM502WP Carey MBA –Class of 2014Tempe Campus

Page 2: India medical device healthcare

Introduction

Republic of India: Facts and Figures

• Location: South Asian country. • 1.2 billion population, 2nd most populous country• 3rd largest economy in Asia and expected to be 3rd largest in the

world by 2050. • Steady GDP growth rate of 8.5% in last 5 years.

Demographics

• 28 states and 7 union territory • 30 official languages + English is widely spoken • World’s largest democracy • Currency is rupees 1 USD = 54.47 INR (www.xe.com @ 12/7/12)

Page 3: India medical device healthcare

Foreign Direct Investment

• 1991 brought the economic reforms• 3rd Most favorite nation for Foreign Direct Investment (FDI)• $58 Bilateral Indo-US trade (2011)

Page 4: India medical device healthcare
Page 5: India medical device healthcare

Healthcare/Medical Technology Market

• $80 billion Healthcare market (KPMG, 2012)

• Expect to reach $280 billion in 2020

• Steady growth of approx. 15%

• $11 billion Pharma market• Expect to reach $74 billion in

2020 (Ernst & Young)

• $5 billon Medical Device market

• Expect to reach CAGR of 15% (KPMG)

Page 6: India medical device healthcare

Why India?• 2.3% medical device excise Tax in US from 2013• India increases its government share of healthcare expenditure to 2.5%

by 2017 (12th 5 year plan)

http://www.emergogroup.com/files/2012-medical-device-industry-survey.pdf

Page 7: India medical device healthcare

SWOT AnalysisStrength Weakness

• Hugh market opportunity• English speaking population • World’s largest democracy, stable

democratic govt.• Low cost manufacturing• currency restrictions and reduce tariffs• SEZ (Special Economic Zones)• Tax break holiday • Second largest pool of scientist and

engineer• IFRS Based Accounting practice • Medical tourism

• Slow Reforms Process• The Long List Syndrome• The No Follow –through Syndrome • Lack of infrastructure • Political corruption • Trade barriers • Poor productivity record, FDI, Economic

reforms• Delay in dispute resolution

Opportunity Threats• Rapidly growing market • Small Distributorship Advantage• Middle class disposable income • Change in lifestyle of urban Indians• 1 billion+ market • Foreign Direct Investment Entry

• Fraud and Reliability Checks • Corruption and bribery• Poor copyright law• Foreign relations • Piracy • Social blunders • Macroeconomic concerns (inflation, etc.)

Page 8: India medical device healthcare

CGMS

• Continuous Glucose Monitoring System

New Class III deviceEffective management of blood glucose levelsComponents: Sensor, transmitter & a wireless

monitorAlerts the patient Downloadable data

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) http://diabetes.niddk.nih.gov/dm/pubs/glucosemonitor/index.aspx

Page 9: India medical device healthcare

• IndiaPatient base of 63 millionCauses for prevalence:

• Insulin resistance• Abdominal adiposity• Low adiponectin • Higher C-reactive protein• Diet and lifestyle

• Major impediments: Cost and affordability

International Diabetes Federation http://www.idf.org/sites/default/files/IDF_SEA_5E_Update_FactSheet.pdf

Mohan, V., Sandeep, S., Deepa, R., Shah, B., & Varghese, C. (2007). Epidemiology of type 2 diabetes: Indian scenario. The Indian journal of medical research, 125(3), 217-30.

Indian Human Development Surveyhttp://ihds.umd.edu/incomeRU.html

CGMS

Page 10: India medical device healthcare

Recommendation

• Invest in Indian Market– Medical Device Market growth rate of 15%– “We can expect 12%–16% annual growth over the next 10 to 15 years. All the risk factors

put together are just irritants, which at most can bring growth to 8%–9%. This is still significantly higher than the 2%–3% growth that developed, Western markets are currently experiencing.”

Annaswamy Vaidheesh - Johnson & Johnson

– Emergent Middle Class• Additional 580 million customers

– Growth of Insurance Market

Page 11: India medical device healthcare

Recommendation Investment Strategy

• Short-Term Strategy – Develop local distribution to distribute Tier 1 products

• Minimize fixed investment • Maintain flexibility • Utilize local sales force

• Long-Term Strategy – Invest in Manufacturing facilities

• Initially produce Tier 2-3 products• 100% Foreign Direct Investment• Utilize Indian facility to supply Asian markets• As markets mature manufacture Tier 1 products